Related Experiment Videos
Labeling efficiency and stomach concentration in methylene diphosphonate bone imaging.
Summary
Tc-999m-labeled methylene diphosphonate (MDP) imaging shows stomach uptake in most patients after 4.75 hours. To avoid stomach concentration, use the reconstituted radiotracer within 4-5 hours due to product breakdown.
Area of Science:
- Nuclear medicine
- Radiopharmacy
- Diagnostic imaging
Background:
- Tc-99m-labeled methylene diphosphonate (MDP) is a common radiotracer for bone scintigraphy.
- Optimal imaging requires minimizing non-target organ uptake, such as the stomach.
Purpose of the Study:
- To investigate the relationship between the time after reconstitution of Tc-99m-MDP and the incidence of stomach concentration.
- To determine the stability of Tc-99m-MDP and its impact on diagnostic imaging.
Main Methods:
- Tc-99m-MDP was prepared and administered to patients at various time points post-reconstitution.
- Patient imaging included assessment of radiotracer distribution, specifically noting stomach uptake.
- Radiotracer stability was inferred through the correlation of time and breakdown products.
Main Results:
- Stomach concentration of Tc-99m-MDP was observed in the majority of patients when administered 4.75 hours after reconstitution.
- The incidence and intensity of stomach uptake increased progressively with time post-reconstitution.
- Increased product breakdown correlated with higher levels of stomach concentration.
Conclusions:
- The reconstituted Tc-99m-MDP radiotracer exhibits time-dependent instability.
- To prevent undesirable stomach concentration in diagnostic imaging, the use of reconstituted Tc-99m-MDP should be limited to within 4-5 hours of preparation.